Skip to content

All Lessons


Session 2: Research to Support Guidance Development for Topical Drug Products

Session 3: Innovative Strategies for Neonatal and Rare Disease Clinical Trials (Part 1)

Session 3: Innovative Strategies for Neonatal and Rare Disease Clinical Trials (Part 2)

Session 3: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 3: Presentations (FDA Generic Drug Science Workshop 2025)

Session 3: Q&A Panel (Advancing Generic Drug Development 2025)

Session 3: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 3: Research to Support Guidance Development for Inhalation Drug Products

Session 4: Opportunities to Enhance Access to and Use of Epinephrine & Closing Remarks

Session 4: Outlook for Drug-Device Combination Products

Session 4: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 4: Presentations (FDA Generic Drug Science Workshop 2025)

Session 4: Q&A Panel and Day Two Closing (Advancing Generic Drug Development 2025)

Session 4: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 4: Regulatory Landscape and Future Directions for Neonatal and Rare Disease Drug Development

Session 5: Panel Discussion (FDA Generic Drug Science Workshop 2025)

Session 5: Presentations (FDA Generic Drug Science Workshop 2025)

Session 5A: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 5A: Spotlight Generic Drug Review Challenges and Solutions

Session 5B: Question & Answer Panel (Advancing Generic Drug Development 2024)

Session 5B: Spotlight Generic Drug Review Challenges and Solutions

Session 6: Ensuring Efficient and Consistent High Quality Generic Drug Development

Session 6: Question & Answer Panel (Advancing Generic Drug Development 2024)

SME Triage Team Case Study: Complex Implant Products – Excipient Sameness, Characterization and Bioequivalence Challenges

SME Triage Team: Office of Pharmaceutical Quality Research & Office of Research and Standards Product-Specific Guidance Development

Share: